CRP and coronary artery disorder: In a separate study involving 5472 participants without CAD over a 5-year period, lovastatin was found to reduce CRP levels by 14.8%, demonstrating efficacy in preventing coronary events in participants with reduced TC/HDL-C ratios but elevated CRP levels [43].